Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9

1.

ER Translocation of the MAPK Pathway Drives Therapy Resistance in BRAF-Mutant Melanoma.

Ojha R, Leli NM, Onorati A, Piao S, Verginadis II, Tameire F, Rebecca VW, Chude CI, Murugan S, Fennelly C, Noguera-Ortega E, Chu CT, Liu S, Xu X, Krepler C, Xiao M, Xu W, Wei Z, Frederick DT, Boland G, Mitchell TC, Karakousis GC, Schuchter LM, Flaherty KT, Zhang G, Herlyn M, Koumenis C, Amaravadi RK.

Cancer Discov. 2019 Mar;9(3):396-415. doi: 10.1158/2159-8290.CD-18-0348. Epub 2018 Dec 18. Erratum in: Cancer Discov. 2019 Jul;9(7):981.

PMID:
30563872
2.

PPT1 Promotes Tumor Growth and Is the Molecular Target of Chloroquine Derivatives in Cancer.

Rebecca VW, Nicastri MC, Fennelly C, Chude CI, Barber-Rotenberg JS, Ronghe A, McAfee Q, McLaughlin NP, Zhang G, Goldman AR, Ojha R, Piao S, Noguera-Ortega E, Martorella A, Alicea GM, Lee JJ, Schuchter LM, Xu X, Herlyn M, Marmorstein R, Gimotty PA, Speicher DW, Winkler JD, Amaravadi RK.

Cancer Discov. 2019 Feb;9(2):220-229. doi: 10.1158/2159-8290.CD-18-0706. Epub 2018 Nov 15.

PMID:
30442709
3.

Intravesical Mycobacterium brumae triggers both local and systemic immunotherapeutic responses against bladder cancer in mice.

Noguera-Ortega E, Rabanal RM, Gómez-Mora E, Cabrera C, Luquin M, Julián E.

Sci Rep. 2018 Oct 10;8(1):15102. doi: 10.1038/s41598-018-33253-w.

4.

Autophagy in the Tumor or in the Host: Which Plays a Greater Supportive Role?

Noguera-Ortega E, Amaravadi RK.

Cancer Discov. 2018 Mar;8(3):266-268. doi: 10.1158/2159-8290.CD-18-0076.

5.

Mycobacteria Clumping Increase Their Capacity to Damage Macrophages.

Brambilla C, Llorens-Fons M, Julián E, Noguera-Ortega E, Tomàs-Martínez C, Pérez-Trujillo M, Byrd TF, Alcaide F, Luquin M.

Front Microbiol. 2016 Oct 4;7:1562. eCollection 2016.

6.

Mycobacteria emulsified in olive oil-in-water trigger a robust immune response in bladder cancer treatment.

Noguera-Ortega E, Blanco-Cabra N, Rabanal RM, Sánchez-Chardi A, Roldán M, Guallar-Garrido S, Torrents E, Luquin M, Julián E.

Sci Rep. 2016 Jun 6;6:27232. doi: 10.1038/srep27232.

7.

Nonpathogenic Mycobacterium brumae Inhibits Bladder Cancer Growth In Vitro, Ex Vivo, and In Vivo.

Noguera-Ortega E, Secanella-Fandos S, Eraña H, Gasión J, Rabanal RM, Luquin M, Torrents E, Julián E.

Eur Urol Focus. 2016 Apr;2(1):67-76. doi: 10.1016/j.euf.2015.03.003. Epub 2015 Jun 6.

PMID:
28723453
8.

γ Irradiated Mycobacteria Enhance Survival in Bladder Tumor Bearing Mice Although Less Efficaciously than Live Mycobacteria.

Noguera-Ortega E, Rabanal RM, Secanella-Fandos S, Torrents E, Luquin M, Julián E.

J Urol. 2016 Jan;195(1):198-205. doi: 10.1016/j.juro.2015.07.011. Epub 2015 Jul 10.

PMID:
26165584
9.

Killed but metabolically active Mycobacterium bovis bacillus Calmette-Guérin retains the antitumor ability of live bacillus Calmette-Guérin.

Secanella-Fandos S, Noguera-Ortega E, Olivares F, Luquin M, Julián E.

J Urol. 2014 May;191(5):1422-8. doi: 10.1016/j.juro.2013.12.002. Epub 2013 Dec 10.

PMID:
24333111

Supplemental Content

Loading ...
Support Center